[Various kinds of antiparkinson agents and their characteristics].
D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000145:classification / Q000494:pharmacology; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D065098:Catechol O-Methyltransferase Inhibitors; D018680:Cholinergic Antagonists; D018491:Dopamine Agonists; D004361:Drug Tolerance; D004409:Dyskinesia, Drug-Induced; D006801:Humans; D007980:Levodopa; D001523:Mental Disorders / Q000139:chemically induced; D008996:Monoamine Oxidase Inhibitors
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D018680:Cholinergic Antagonists; D018491:Dopamine Agonists; D008996:Monoamine Oxidase Inhibitors; D007980:Levodopa